Celcuity Inc (CELC)
16.60
-1.06
(-6.00%)
USD |
NASDAQ |
May 20, 10:38
Celcuity Price to Book Value: 3.876 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.914 |
| May 16, 2024 | 4.124 |
| May 15, 2024 | 4.024 |
| May 14, 2024 | 3.944 |
| May 13, 2024 | 3.916 |
| May 10, 2024 | 3.930 |
| May 09, 2024 | 4.052 |
| May 08, 2024 | 4.112 |
| May 07, 2024 | 4.073 |
| May 06, 2024 | 4.105 |
| May 03, 2024 | 4.066 |
| May 02, 2024 | 4.064 |
| May 01, 2024 | 3.751 |
| April 30, 2024 | 3.629 |
| April 29, 2024 | 3.693 |
| April 26, 2024 | 3.663 |
| April 25, 2024 | 3.629 |
| April 24, 2024 | 3.898 |
| April 23, 2024 | 3.967 |
| April 22, 2024 | 4.036 |
| April 19, 2024 | 3.967 |
| April 18, 2024 | 3.772 |
| April 17, 2024 | 3.914 |
| April 16, 2024 | 3.965 |
| April 15, 2024 | 4.163 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.213 |
| April 11, 2024 | 4.531 |
| April 10, 2024 | 4.460 |
| April 09, 2024 | 4.579 |
| April 08, 2024 | 4.510 |
| April 05, 2024 | 4.595 |
| April 04, 2024 | 4.579 |
| April 03, 2024 | 4.602 |
| April 02, 2024 | 4.519 |
| April 01, 2024 | 4.782 |
| March 28, 2024 | 4.706 |
| March 27, 2024 | 3.957 |
| March 26, 2024 | 3.817 |
| March 25, 2024 | 3.878 |
| March 22, 2024 | 3.874 |
| March 21, 2024 | 3.839 |
| March 20, 2024 | 3.876 |
| March 19, 2024 | 3.577 |
| March 18, 2024 | 3.543 |
| March 15, 2024 | 3.527 |
| March 14, 2024 | 3.539 |
| March 13, 2024 | 3.569 |
| March 12, 2024 | 3.547 |
| March 11, 2024 | 3.266 |
| March 08, 2024 | 3.387 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.298
Minimum
May 13 2022
16.72
Maximum
Mar 18 2021
5.032
Average
3.598
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.922 |
| AIM ImmunoTech Inc | 2.195 |
| IGC Pharma Inc | 3.872 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.818 |
Price to Book Value Related Metrics
| Price | 16.60 |
| Earnings Yield | -16.69% |
| Market Cap | 518.42M |